Medical Innovation Exchange

Equillium cancels Metacrine buy, citing ‘strong financial position’ after Ono deal

https://www.fiercebiotech.com/biotech/equillium-cancels-metacrine-buy-citing-strong-financial-position-after-ono-deal

Leave a Comment

Your email address will not be published. Required fields are marked *

Leave the field below empty!